Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Federal Rules Limit “Junk” Health Plans

By Ada Janocinska on April 4, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

On March 28, the U.S. Departments of Health and Human Services, Labor and the Treasury collectively issued final rules with respect to short-term and limited duration insurance (STLDI) plans in an effort to reduce healthcare costs by protecting consumers from purchasing such “junk” health plans that may provide little to no coverage in many scenarios. A Fact Sheet on the final rules is available on the Centers for Medicare & Medicaid Services website.

STLDI plans are typically intended to fill temporary gaps in healthcare coverage. However, these plans are not subject to the consumer protections that were imposed by the Affordable Care Act, such as guaranteed coverage for consumers with pre-existing conditions and non-discrimination based on health status, age or gender. As a result, STLDI plans have all too often been deceptively marketed and misused.

Starting September 1, 2024, the final rules will limit the permissible duration of STLDI plans to no more than three months for the initial term and a maximum of four months of coverage after taking into account any extensions or renewals. This is a significant reduction from the three-year maximum duration that previously applied to these plans.

The new rules also require insurance companies to provide a clear and easy-to-understand notice to consumers with marketing, enrollment and re-enrollment information to help consumers make informed decisions when purchasing coverage under an STLDI plan. The goal is to ensure that consumers do not inadvertently purchase STLDI plans as a substitute for long-term comprehensive coverage.

Sign up to receive Rivkin Rounds at www.RivkinRounds.com.

Photo of Ada Janocinska Ada Janocinska
Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Rivkin Rounds
  • Organization:
    Rivkin Radler
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo